Paul Song, MD
Paul Y. Song, MD is a member of the Department of Radiation Oncology at Cedars-Sinai’s Samuel Oschin Cancer Center. He is board-certified by American Board of Therapeutic Radiology and Oncology.
Dr. Song's research focuses on prostate cancer, head and neck cancers, sarcomas and gynecologic malignancies. He has extensive brachytherapy experience using both low dose radioactive seeds and also high dose Iridium-192 for various tumors throughout the body. Dr. Song has published several articles on the treatment of prostate cancer and brain tumors.
After graduating with honors from the University of Chicago, Dr. Song earned his medical degree at George Washington University. He completed a residency in radiation oncology at the University of Chicago, where he served as chief resident. At the University of Chicago, he was honored as a research fellow for 1995-96 by the American Society for Therapeutic Radiology and Oncology (ASTRO) for his research in genetic radiotherapy. Dr. Song was also a visiting brachytherapy fellow at the Institut Gustave Roussy in Villejuif, France.
Prior to joining Cedars-Sinai, Dr. Song served as an attending physician at Inova Fairfax Hospital, Co-chief of the brachytherapy service at the Center for Prostate Disease Research at Walter Reed Army Medical Center, medical director of the Little Company of Mary / University of Chicago Radiation Oncology Department and most recently as an adjunct faculty member at the John Wayne Cancer Institute. He was named one of the top doctors in Washington, DC by Washingtonian Magazine and Consumer Checkbook in 2002 and 2005.
Click here to learn more about Dr. Paul Y. Song.